Apexian Pharmaceuticals: Apexian Chief Scientific Officer Awarded $2.3 Million National Cancer Institute Grant

Research focuses on ChemotherapyInduced Peripheral Neuropathy Apexian Pharmaceuticals Chief Scientific Officer Dr. Mark Kelley has been awarded $2.3 million by the National Cancer Institute NCI to research the effects of APX3330 ...